Clinical Evaluation of plasma Gelsolin as a novel marker for sepsis: comparison with Procalcitonin regarding early diagnosis and prognosis in septic patients

Citation:
Aqabawy, H. E., E. Omer, H. Mowafy, I. Nessim, and A. Maghraby, "Clinical Evaluation of plasma Gelsolin as a novel marker for sepsis: comparison with Procalcitonin regarding early diagnosis and prognosis in septic patients", Biolife, vol. 5, issue 4, pp. 416-427, 2017.
PreviewAttachmentSize
416-427.pdf1.05 MB